Data protection and confidential information

In the dynamic realm of life sciences, safeguarding data and ensuring confidentiality is paramount. Equip yourself with the essential knowledge and tools to protect sensitive information, adhere to regulatory frameworks, and manage potential breaches effectively. Stay ahead of evolving legislation and industry standards to mitigate risks and uphold the integrity of your practice.

View Life Sciences by content type:

Latest Life Sciences News

Commission accepts Sanofi commitments to address possible anticompetitive disparagement of competing flu vaccine

The European Commission has accepted commitments offered by Sanofi and made them legally binding under EU antitrust rules to address concerns that...

MHRA publishes Strategy 2030 outlining plans to modernise medicines and medical devices regulation

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2030 Strategy, setting out how it will modernise regulation to keep...

EFPIA calls for suspension of EU Urban Wastewater Treatment Directive implementation

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called on the European Commission to suspend implementation of the...

Shakeup of UK rules for AI in healthcare puts stress on device evolution

MLex: Draft UK guidance on managing changes to AI-enabled medical devices is due by December, and a consultation on classifying them is planned by...

Featured Life Sciences content

Introduction to technology transfer agreements in the Life Sciences industry

Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...

Regulation of cosmetic products in the UK

Regulation of cosmetic products in the UKThis Practice Note provides an overview of the UK regulatory framework for cosmetics. It sets out the legal...

Intellectual property protection for medical devices

Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...

Second and subsequent medical use patent claims

Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...

Practice notes

The experimental use and Bolar-type exemptions to patent infringement

The experimental use and Bolar-type exemptions to patent infringementPatent systems are intended to foster innovation, not to impede it. For this...

Read More >

Produced in partnership with Charlie French of Bristows and Milly Wickson of Bristows

13th Oct

In-house

News

The 2024 ABPI Code of Practice—what are the key proposed changes?

The PMCPA has recently launched a consultation to update:•the 2021 ABPI Code of Practice•the Constitution and Procedure which sets out how...

Read More >

3rd Jun

News

MHRA releases guidance on pharmacovigilance following Windsor Framework agreement

The Medicines and Healthcare products Regulatory Agency (MHRA) has released guidance on the implementation of changes to pharmacovigilance for...

Read More >

3rd Jun

Practice notes

The regulation of medical devices in the UK

The regulation of medical devices in the UKThis Practice Note provides an overview of the UK regulatory regime for medical devices. It explains the...

Read More >

30th May

Brexit